Admission Date: [**2182-7-10**]        Discharge Date: [**2182-7-30**]  Date of Birth:  [**2114-1-4**]        Sex:  F  Service:  MED   HISTORY OF PRESENT ILLNESS:  This is a 68-year old female with a history of myelodysplastic syndrome transformed into acute myelogenous leukemia (type M6A) diagnosed one month ago who was initially admitted for treatment with low-dose Ara-C and Hydroxyurea.
Her disease was initially diagnosed secondary to pancytopenia with circulating blast forms and a bone marrow in [**2182-5-9**].
She was initially treated with Procrit and weekly transfusions with packed red blood cells and Danazol from which she developed an allergic reaction.
MEDICATIONS ON ADMISSION:  Procrit 40,000 units every week and Tylenol as needed.
She    was treated with 13 days of low-dose Ara-C as well as    Hydroxyurea.
She was treated initially with a one time    dose of GM-CSF which was then discontinued secondary to    fevers.
AmBisome was eventually started for    continued fevers, but then discontinued secondary to acute    renal failure and switched to voriconazole.
The patient was empirically started on linezolid, and the vancomycin was discontinued.
Gastroenterology was consulted and is following, holding    off on colonoscope at this time.
She given vitamin K, as    well as amicrobic acid, and Protonix twice per day.
She    requires HLA typed and matched platelets secondary to    antibodies.
She was given multiple boluses of intravenous fluids    without significant improvement in her pressures.
She was started on low-dose    dopamine for renal perfusion.
The    patient was also started on Bicitra 30 twice per day.
PULMONARY ISSUES:  The patient was continued on albuterol    and Atrovent nebulizers for chronic obstructive pulmonary    disease seen on computerized axial tomography with a    longstanding history of smoking.
The patient was started    clobetasol and bacitracin topically as well as Sarna    lotion for pruritus.
FLUIDS/ELECTROLYTES/NUTRITION ISSUES:  The patient was    continued on a full liquid diet.
PROPHYLAXIS ISSUES:  Proton pump inhibitor and bowel    regimen.
ACCESS ISSUES:  Hickman catheter and peripheral lines.
